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Abstract
Background: Helicobacter pylori (H. pylori) infection is associated with chronic gastritis, peptic ulceration and gastric
carcinoma. Protease-activated receptor-2 (PAR-2), which is activated by trypsin, induced the activation of mitogen-
activated protein kinases (MAPK), cell proliferation and apoptosis in several cells. Previously, we found that H. pylori
induces the expression of PAR-2, which mediates the expression of adhesion molecules integrins in gastric
epithelial cells. In the present study, the role of PAR-2 on H. pylori-induced cell death was investigated by
determining cell viability, DNA fragmentation, and the activation of MAPK in gastric epithelial AGS cells.
Methods: AGS cells were cultured in the presence of H. pylori transfected with PAR-2 antisense (AS)
oligonucleotide (ODN) or treated with a soybean trypsin inhibitor (SBTI). Viable cells and DNA fragmentation were
determined by trypan blue exclusion assay and the amount of oligonucleosome-bound DNA, respectively. The
activation of MAPK such as extracellular signal-regulated kinases (ERK), p38, and c-Jun N-terminal kinases (JNK), was
assessed by Western blotting for phospho-specific forms of MAPK.
Results: H. pylori-induced cell death and DNA fragmentation augmented in the cells transfected with PAR-2 AS
ODN or treated with SBTI. The activation of MAPK, induced by H. pylori, were suppressed by transfection with PAR-
2 AS ODN or treatment with SBTI.
Conclusion: PAR-2, whose expression is induced by H. pylori, may prevent cell death and DNA fragmentation with
the activation of MAPK in gastric epithelial cells.
Background
Helicobacter pylori (H. pylori) has been shown to be an
important pathogen of gastroduodenal inflammation
and gastric carcinogenesis [1,2]. H. pylori infection
increases epithelial apoptosis in gastric mucosa, which
may play an important role in gastric carcinogenesis [3].
H. pylori-induced apoptosis may stimulate compensatory
hyperproliferation which results in potential preneoplas-
tic changes in chronic H. pylori infection [4-6]. H. pylori
-induced apoptosis has been shown in gastric epithelial
cells [7,8] as well as infected gastric tissues [6,9,10].
However, the apoptotic mechanism induced by H. pylori
infection has not been fully elucidated.
H. pylori activates three main groups of mitogen-acti-
vated protein kinases (MAPKs), i.e., the extracellular sig-
nal-regulated kinases 1 and 2 (ERK1/2), p38 MAPKs,
and c-Jun N-terminal kinases [11,12]. Recently, it was
shown that inhibition of the ERK1/2 pathway augmen-
ted H. pylori-induced apoptosis in gastric epithelial cells
[13], demonstrating the possible involvement of MAPK
in gastric apoptosis.
Proteinase-activated receptors (PARs), a family of G
protein-coupled seven-trans-membrane domain recep-
tors, mediate a variety of intracellular signaling and sub-
sequent cellular events caused by specific extracellular
proteinases [14,15]. The family of PARs currently
includes four members: PAR-1, PAR-2, PAR-3 and
PAR4. The coagulant protease thrombin is the physiolo-
gical activator of PAR-1, PAR-3, and PAR-4. PAR-2 is
activated by multiple trypsin-like serine proteases
including trypsin, tryptase and coagulation protease
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activation of multiple signaling pathways, including
MAPK cascades in distinct cell types [16,17]. PAR-2 is
involved in cell proliferation and apoptosis in several
cell types [18,19]. Recent data suggest that activation of
PAR-2 rescued cells from apoptosis via activation of
MAPKs [20]. We previously demonstrated that H. pylori
induces the activation and expression of PAR-2 in gas-
tric epithelial cells [21,22]. These results demonstrate
t h ep o s s i b l er e l a t i o n so ft h ee x p r e s s i o no fP A R - 2 ,t h e
activation of MAPK, and apoptosis in H. pylori-infected
gastric epithelial cells. The present study aims to investi-
gate whether H. pylori-induced apoptotic cell death is
related to the expression of PAR-2 and the activation of
MAPK in gastric epithelial cells.
Methods
Bacterial strain
An H. pylori strain used in the present study is HP99
isolated form Korean patients and identified as cagA+,
vacA+ strain [12]. HP99 is kindly provided from Dr. H.
C. Jung (Seoul National University College of Medicine,
Seoul, Korea). These bacteria were inoculated onto cho-
colate agar plates (Becton Dickinson Microbiology
Systems, Cockeysville, MD, USA) at 37°C under micro-
aerophilic conditions using an anaerobic chamber (BBL
Campy Pouchs System, Becton Dickinson Microbiology
Systems).
Cell culture and H. pylori stimulation
A human gastric epithelial cell line AGS (gastric adeno-
carcinoma, ATCC CRL 1739) was obtained from the
American Type Culture Collection (Rockville, MD,
USA). The cells were grown in complete medium, con-
sisting of RPMI 1640 medium supplemented with 10%
fetal bovine serum, 2 mM glutamine, 100 U/ml penicil-
lin, and 100 μg/ml streptomycin (Sigma, St. Louis, MO,
USA). AGS cells were seeded and cultured to reach 80%
confluency. Prior to the stimulation, each dish was
washed twice with fresh cell culture medium containing
no antibiotics. H. pylori was harvested, washed with
phosphate buffered saline (PBS), and then resuspended
into antibiotic-free cell culture medium. H. pylori was
added to AGS cells at bacterium/cell ratio of 150:1 or
300:1, and cultured for the indicated time periods.
Experimental protocol
To investigate the relations of apoptotic cell death, the
expression of PAR-2, and the activation of MAPK in H.
pylori-infected gastric epithelial cells, cell viability and
DNA fragmentation were determined in the cells trans-
fected with PAR-2 AS ODN or S ODN or treated with
soybean trypsin inhibitor (SBTI; 0.2 μM, 0.5 μM) and
c u l t u r e di nt h ep r e s e n c eo fH. pylori at bacterium/cell
ratio of 150:1 (cell viability) or 300:1 (cell viability, DNA
fragmentation) for 24 hours. For the activation of
MAPK, AGS cells were transfected with PAR-2 AS
ODN or S ODN or treated with soybean trypsin inhibi-
tor (SBTI; 0.2 μM, 0.5 μM) and cultured in the presence
of H. pylori at bacterium/cell ratio of 300:1 for 30 min-
utes. To determine the transfection efficiency of PAR-2
AS ODN or S ODN, the level of PAR-2 was determined
in the transfected cells cultured in the presence of
H. pylori at bacterium/cell ratio of 300:1 for 2 hours.
Determination of cell viability and DNA fragmentation
AGS cells were cultured in the presence of H. pylori at a
bacterium/cell ratio of 150:1 or 300:1 for 24 hours.
Viable cells were determined by trypan blue exclusion
test (0.2% trypan blue). DNA fragmentation was deter-
mined by the amount of oligonucleosome-bound DNA
in the cell lysates using a sandwich ELISA (Cell Death
Detection ELISAplus kit; Boehringer-Mannheim). The
relative increase in oligonucleosome-bound DNA was
determined at 405 nm and expressed as an enrichment
factor.
Treatment with ODNs using cationic liposome
Single-stranded oligonuceltides (ODNs) were produced
commercially (GIBCO BRL, Rockville, MD, USA). ODNs
were phosphorothioate-modified to reduce intracellular
nuclease digestion. Antisense (AS) and sense (S) ODNs
targeted the ATG start codon of the human PAR-2
mRNA [GenBank: AY336105.1]. The sequence of the
PAR-2 AS ODN was 5′TCCGCATCCTCCTGGAA3′.
T h es e q u e n c eo fP A R - 2SO D Nw a s5 ′TTCCAGGAG-
GATGCGGA3′. AGS cells were transfected with ODNs
using a cationic liposome, a commercially available trans-
fection-reagent DOTAP (N-[1-(2,3-dioleoyloxy) propyl]-
N, N, Ntrimethyl ammonium methylsulfate) (Boehringer-
Mannheim, Pentzberg, Germany) to improve stability
and intracellular delivery of ODNs. When DOTAP was
employed, the appropriate amount of ODNs were incu-
bated with DOTAP (15 μl/ml) to achieve the respective
final concentration of the ODNs to 0.5 μMa t3 7 ° Cf o r
15 min. The cells were treated with the mixture and then
incubated for 24 hours. After medium was changed with
antibiotic-free medium, the transfected cells were cul-
tured in the presence of H. pylori.
Western blot analysis
One hundred μg of whole cell extracts was loaded per
lane, separated by SDS-polyacrylamide gel electrophor-
esis (PAGE) under reducing conditions, and transferred
onto Hybond-PVDF membranes (Amersham Inc.,
Arlington Heights, IL, USA) by electroblotting. The
transfer of protein and equality of loading in all lanes
was verified using reversible staining with Ponceau S.
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PAR-2, ERK1/2, p38, and JNK1/2 were detected by
incubation of blots with specific polyclonal antibodies,
followed by sheep anti-mouse secondary antibody conju-
gated to horseradish peroxidase. The proteins were
determined by enhanced chemiluminescence (Amer-
sham) using exposure to BioMax MR film (Kodak).
Statistical analysis
Results are expressed as means ± standard error of four
separate experiments. Analysis of variance (ANOVA)
followed by Newman-Keul’s test was used for statistical
analysis. P< 0.05 was considered statistically significant
Results
Inhibition of PAR-2 expression augments H. pylori-
induced cell death and DNA fragmentation in gastric
epithelial cells
To investigate the relations of PAR-2 expression, cell
death, and DNA fragmentation, cells were transfected
with AS ODN for PAR-2 and cultured in the presence
of H. pylori. As shown in figure 1, H. pylori induced the
expression of PAR-2, which was inhibited in the cells
transfected with PAR-2 AS ODN. Viable cell numbers
were decreased by H. pylori with the number of bacter-
ium infected to the cells (Figure 2A). Cell death of
H. pylori-infected cells was augmented by transfection
with PAR-2 AS ODN, compared with that of the cells
transfected with S ODN or wild cells (non-transfected
cells). Similarly, H. pylori-induced DNA fragmentations
increased by transfection with PAR-2 AS ODN, com-
pared with corresponding S ODN or wild cells (Figure
Figure 1 Transfection of AS ODN for PAR-2 inhibits the
expressiongn of PAR-2 in H. pylori-infected AGS cells. AGS cells
were transfected with PAR-2 AS ODN or S ODN for 24 hours and
cultured in the absence or the presence of H. pylori at a bacterium/
cells ratio of 300:1 for 2 hours. The levels of PAR-2 were determined
by Western blot analysis using specific antibody for PAR-2. Actin
served as a loading control. Wild, the cells without transfection;
Transfected, the cells transfected with S ODN (S) or AS ODN (AS).
None, the cells without transfection and cultured in the absence of
H. pylori; H. pylori control, the cells without transfection and cultured
in the presence of H. pylori.
Figure 2 Inhibition of PAR-2 expression augments H. pylori-
induced cell death and DNA fragmentation in AGS cells. (A)
AGS cells were transfected with PAR-2 AS ODN or S ODN for 24
hours and cultured in the absence or the presence of H. pylori at a
bacterium/cells ratio of 150:1 or 300:1 for 24 hours. Viable cell
numbers were determined by trypan blue exclusion test. The results
represent mean ± SE of four different experiments. *P < 0.05
compared to the corresponding none (the cells cultured in the
absence of H. pylori ).
+P < 0.05 compared to the corresponding
wild or PAR-2 S (wild cells or the cells transfected with S ODN and
cultured in the presence of H. pylori at a bacterium/cells ratio of
150:1 or 300:1). (B) AGS cells were transfected with PAR-2 AS ODN
or S ODN for 24 hours and cultured in the absence or the presence
of H. pylori at a bacterium/cells ratio of 300:1 for 24 hours. DNA
fragmentation was determined by the amount of oligonucleosome-
bound DNA in the cell lysates. The relative increase in
oligonucleosome-bound DNA was determined at 405 nm and
expressed as an enrichment factor. The results represent mean ± SE
of four different experiments. *P < 0.05 compared to none control
(the cells without transfection and cultured in the absence of H.
pylori).
+P < 0.05 compared to wild H. pylori control (the cells
without transfection and cultured in the presence of H. pylori). Wild,
the cells without transfection; Transfected, the cells transfected with
S ODN (S) or AS ODN (AS).
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expression of PAR-2 may have a protective role against
apoptosis of gastric epithelial cells, determined by cell
death and DNA fragmentation.
Inhibition of PAR-2 expression suppresses H. pylori-
induced activation of MAPK in gastric epithelial cells
To determine the role of PAR-2 on the activation of
MAPK, the activation of three major MAPK involved in
cell proliferation and apoptosis were assessed by Wes-
tern blotting of phospho-specific and total forms of
MAPK (p38, ERK1/2, JNK1/2). As shown figure 3, levels
of phospho-specific forms of p38, ERK1/2, and JNK1/2
increased by H. pylori in AGS cells. H. pylori did not
affect total forms of p38, ERK1/2, and JNK1/2 in AGS
cells. H. pylori-induced activation of MAPK was inhib-
ited in the cells transfected with PAR-2 AS ODN, but
that was not affected in the cells transfected with S
ODN. These results demonstrate that both H. pylori-
induced expression of PAR-2 and activation of MAPK
may be related to cell viability of gastric epithelial cells
after H. pylori infection.
Soybean trypsin inhibitor (SBTI) augments H. pylori-
induced cell death and DNA fragmentation in gastric
epithelial cells concentration-dependently
Since PAR-2 is activated by trypsin [14,15], SBTI was
treated to the cells and cultured in the presence of
H. pylori to suppress the activity of PAR-2. Viable cell
numbers were decreased by H. pylori with the number
of bacterium infected to the cells (Figure 4A). Cell death
of H. pylori-infected cells was augmented by treatment
of SBTI concentration-dependently. H. pylori-induced
DNA fragmentations increased by treatment of 0.5 μM
of SBTI (Figure 4B). These results suggest that inhibi-
tion of trypsin activity, which induces the suppression of
PAR-2 activity, augments H. pylori- induced cell death
and DNA fragmentation.
Soybean trypsin inhibitor (SBTI) suppresses H. pylori-
induced activation of MAPK in gastric epithelial cells
H. pylori -induced increases in phospho-specific forms
of p38, ERK1/2, and JNK1/2 were inhibited by treatment
by treatment of SBTI in AGS cells concentration-depen-
dently (figure 5). As shown figure 3, H. pylori did not
affect total forms of p38, ERK1/2, and JNK1/2 in AGS
cells, which was not affected by treatment of SBTI (fig-
ure 5). These results suggest that PAR2, which may be
activated by trypsin, may be involved in the activation of
MAPK in H. pylori-infected gastric epithelial cells.
Discussion
In the present study, we found that H. pylori-induced
cell death and DNA fragmentation were augmented by
inhibition of PAR-2 expression using PAR-2 AS ODN in
AGS cells. Additionally, inhibition of PAR-2 activity
using trypsin inhibitor increased cell death and DNA
fragmentation in H. pylori-infected AGS cells. These
results demonstrate that the expression and the activa-
tion of PAR-2 induced by H. pylori may prevent apopto-
tic cell death in gastric epithelial cells.
Previously we demonstrated that H. pylori induced the
expression and activation of PAR-2, which mediates the
expression of COX-2 and integrins in gastric epithelial
cells [21,22]. Trypsin activated PAR-2, which mediated
the proliferation of various cells including pancreatic
and gastric cancer cells, and smooth muscle cells
[23-25]. Additionally, activation of PAR-2 by agonist or
activating peptide protects astrocytes and neutrophils
against apoptotic cell death [26,27]. These studies sup-
port the present results showing that H. pylori-induced
expression of PAR-2 may protect gastric epithelial cells
from cell death and DNA fragmentation.
Furthermore, we here found that activation of MAPK
was mediated by PAR-2 in H. pylori-infected gastric
Figure 3 Inhibition of PAR-2 expression suppresses H. pylori-
induced activation of MAPK in gastric epithelial cells. AGS cells
were transfected with PAR-2 AS ODN or S ODN for 24 hours and
cultured in the absence or the presence of H. pylori at a bacterium/
cells ratio of 300:1 for 30 minutes. The levels of phospho-specific
and total forms of MAPK (p38, ERK1/2, JNK1/2) were determined by
Western blotting using specific antibodies for the indicated proteins.
Wild, the cells without transfection; Transfected, the cells transfected
with S ODN (S) or AS ODN (AS). None, the cells without treatment
and cultured in the absence of H. pylori; H. pylori control, the cells
without treatment and cultured in the presence of H. pylori.
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vious studies showing that the activation of PAR-2 is
related to the activation of MAPK in mouse tracheal
and bronchial smooth muscle [16,17]. The MAPK sig-
naling pathways play essential roles in cell proliferation
and apoptosis [18,19]. MAPK activated by H. pylori
infection is involved in apoptosis of gastric epithelial
cells [28-30]. Ding et al. [28] demonstrated that inhibi-
tion on the activation of ERK1/2, JNK1/2 or p38 by
treatment of the chemical inhibitor increased H. pylori-
induced apoptosis in gastric epithelial cells. These stu-
dies suggest that PAR-2 activation induced by H. pylori
may protect gastric epithelial cells from apoptosis by the
activation of MAPK. In contrast, inhibition of p38 by a
specific inhibitor SB203580 decreased apoptosis while
ERK1/2 inhibition by a specific inhibitor PD98059
resulted in an increase of apoptosis in H. pylori-infected
gastric epithelial cells [29]. Further studies should be
performed to investigate the role of PAR-2 on the acti-
vation of specific MAPK and its relation to the expres-
sion of apoptotic genes in H. pylori-infected gastric
epithelial cells. Recently it was reported that other PARs
such as PAR-1 and PAR-4 protect cell apoptosis
through ERK or JNK signaling pathway [30-34]. There-
fore, the expression and activation of PAR-2 induced by
H. pylori may rescue gastric epithelial cells from apopto-
sis via MAPK signaling.
Other possible protective proteins other than PARs,
antiapoptotic proteins such as inhibitors-of-apoptosis-
proteins (IAPs) were induced by NF-B activation and
protected the cells from apoptosis induced by the wild-
type H. pylori containing virulence factor cytotoxin-
associated gene (cagA) [35]. Molecular chaperone heat
shock protein 70 protected gastric injury against
Figure 4 Soybean trypsin inhibitor (SBTI) augments H. pylori-
induced cell death and DNA fragmentation in gastric epithelial
cells concentration-dependently. (A) AGS cells were treated with
SBTI (0.2 μM, 0.5 μM) and cultured in the absence or the presence
of H. pylori at a bacterium/cells ratio of 150: or 300:1 for 24 hours.
Viable cell numbers were determined by trypan blue exclusion test.
The results represent mean ± SE of four different experiments. *P <
0.05 compared to none (the cells without treatment and cultured in
the absence of H. pylori).
+P < 0.05 compared to the corresponding
none (the cells without treatment and cultured in the presence of
H. pylori at a bacterium/cells ratio of 150: or 300:1). (B) AGS cells
were treated with SBTI (0.5 μM) and cultured in the absence or the
presence of H. pylori at a bacterium/cells ratio of 300:1 for 24 hours.
DNA fragmentation was determined by the amount of
oligonucleosome-bound DNA in the cell lysates. The relative
increase in oligonucleosome-bound DNA was determined at 405
nm and expressed as an enrichment factor. The results represent
mean ± SE of four different experiments. *P < 0.05 compared to
none control (the cells without treatment and cultured in the
absence of H. pylori).
+P < 0.05 compared to H. pylori control (the
cells without treatment and cultured in the presence of H. pylori).
Figure 5 Soybean trypsin inhibitor (SBTI) suppresses H. pylori-
induced activation of MAPK in gastric epithelial cells. AGS cells
were treated with SBTI and cultured in the absence or the presence
of H. pylori at a bacterium/cells ratio of 300:1 for 30 minutes. The
levels of phospho-specific and total forms of MAPK (p38, ERK1/2,
JNK1/2) were determined by Western blotting using specific
antibodies for the indicated proteins. None, the cells without
treatment and cultured in the absence of H. pylori; H. pylori control,
the cells without treatment and cultured in the presence of H.
pylori.
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derived hypochlorous acid and H pylori urease-induced
ammonia [36]. H. pylori infection upregulated gastric
mucosal peroxiredoxin (Prx) I expression, and further,
that Prx I played an important role in gastric mucosal
protection against oxidative injury induced by H. pylori
infection [37]. Recently, it was found that the distur-
bances in gastric mucosal NO generation system caused
by H. pylori resulted from the inducible nitric oxide
synthase (iNOS). They demonstrated that peptide
hormone ghrelin protected gastric mucosa from H. pylori-
induced proapoptotic events by a decrease in S-nitrosyla-
tion of constitutive nitric oxide synthase (cNOS) [38].
Regarding virulence factors of H. pylori, cagA and
vacuolating cytotoxin A (vacA) are reported to contri-
bute to gastric cancer incidence [39,40]. Since H. pylori
in Korean isolates, HP99 used in the present study, con-
tains both cagA and vacA [41], the present result may
explain the possible mechanism of H. pylori-induced
gastric carcinogenesis. Further study should be per-
formed to investigate the mechanism of gastric carcino-
genesis involving PAR-2-associated prevention against
apoptosis of gastric epithelial cells infected with
H. pylori containing different isotypes of virulence
factors.
Conclusion
PAR-2, whose expression is induced by H. pylori,m a y
prevent cell death and DNA fragmentation with the
activation of MAPK in gastric epithelial cells. These
results demonstrate a novel mechanism of protection
against apoptotic cell death by PAR-2 in H. pylori-
infected gastric epithelial cells.
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